Paris

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Macular degeneration1 trial
• Pompe disease1 trial

Phase

• Phase 22 trials

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Sanofi2 trials
• Genzyme, a Sanofi Company1 trial

Running trials

• Active, not recruiting

  A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B

  NCT02065011· Phase 2· Sanofi· Source

• Active, not recruiting

  Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration

  NCT01736592· Phase 2· Sanofi· Source

• Recruiting

  Pompe Disease Registry Protocol

  NCT00231400· Genzyme, a Sanofi Company· Source

  Contact: Pompe Registry HelpLine

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Pompe disease1 recruiting